The Connection Between Alzheimer’s Disease and Prion Diseases: A Mini-Review

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 13, Issue 3

Abstract

Alzheimer’s disease and prion diseases are progressive neurodegenerative disorders that have no cure. These illnesses share some similar mechanisms for misfolding, aggregation, accumulation, and dispersion of proteins; moreover, one of the receptors for amyloid beta is the normal prion protein, so several neurodegenerative diseases may share a pathological pathway.Alzheimer’s disease (AD) is a neurodegenerative disease with a slow progression that worsens over time [1]. AD is the main cause of dementia and this syndrome can be characterized by any reduction in cognitive capabilities that interferes with daily life [2]. There are two main forms of AD: early-onset AD, which is rare (≤ 1%), occurs in individuals under 65 years of age, and is caused by genetic mutations. The other form is late-onset AD and this is the most common form. Late-onset AD occurs in individuals 65 years of age and older and it is multifactorial [1]. Prion diseases, also known as transmissible spongiform encephalopathies, are a group of rare infectious neurodegenerative and fatal illnesses that includes Creutzfeldt-Jakob disease, variant Creutzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker disease, fatal familial insomnia, and kuru [3]. In addition to the loss of synapses and neurons in specific brain areas, prion diseases, AD, and other neurodegenerative diseases such as Parkinson’s and Huntington’s disease have several other common features such as the progressive accumulation of misfolded proteins that form amyloid [4].The main proteins involved in the accumulation of misfolded aggregates in AD are extracellular amyloid beta 42 (Aβ42), which forms amyloid plaques, and hyperphosphorylated tau (hp-tau), which forms intracellular neurofibrillary tangles [5]. In contrast, in prion diseases, the aggregates are formed by extracellular abnormal prion protein (PrPSc) [3]. These proteins, in their native form, undergo a misfolding process that produces a structure with β-sheet-rich structures [4]. Several studies support the hypothesis that misfolding, oligomerization, and accumulation of these proteins are the main events that trigger the pathological events in neurons in both AD and prion diseases [6]. Aβ42, hp-tau, and PrPSc aggregation seems to adjust better to the seeding-nucleation model first proposed by Jarret and Lansbury [7]. In their current form, this model can be summarized as follows: the first event is the formation of a nucleus or seed from the misfolded monomeric protein; then, this structure evolves to oligomers, protofibrils, and mature fibrils, which eventually suffer fragmentation and the fragments produced can migrate and function as a new seed which can recruit soluble normal protein and the cycle repeats [4,8]. Of all the structural conformations previously mentioned, the oligomers are the more toxic form [6,9,10]. Experimental evidence shows that normal prion protein (PrPC) can function as an Aβ42 receptor and this interaction produces a decrease in long term potentiation in neurons of the hippocampus [11,12]. Other studies have shown that activation of PrPC stimulates hp-tau [13,14], which suggests that PrPC is an intermediary between Aβ42 and the hyperphosphorylation of tau.

Authors and Affiliations

Hilda Martínez-Coria, Héctor E López-Valdés

Keywords

Related Articles

Active and Smart Ageing: The Use of Technology for Preventive Medicine

The present review shows the need of advances in data analysis of stored information gathered from existing wearable health tracking technologies and the need of AI data interpretation based on large collections of data...

A Novel Micro RNA Feedback Loop of High Mobility Group Protein A1a in Regulating Estrogen Receptor Alpha Alternative Splicing

The hERα gene is known for its major role in estrogen dependent growth of breast cancer. ERα positivity is a hallmark in treating these cancers. Though there are many isoforms reported for hERα, the splicing regulation,...

The Onset of Acne Vulgaris among Adult Women and the Effectiveness of Therapy with Ferulic Acid and D'arsonwal's Currents

Introduction: Acne vulgaris as a skin disease does not only affect young people. It is extremely acute and more common problem among adults, that appears around the age of 25 or lasts continuously from the time of maturi...

Determination of Contact Angle Values of Heat-treated Spruce (Picea abies) Wood with Image Analysis Program

Heat treatment of wood material increases the dimensional stability and prevents cracks on the wood surface formed by rain and harmful rays. In this study, the effect of heat treatment application on the contact angle va...

Small Size Nanosilver Multi Organ Toxicity: A Higher Dose Negative Response in In-Vivo and In-Vitro Experimental Application

Multi organ toxicity of nanosilver depends on shape and injected dose of the particle concerned. But rate of toxicity is based on mode of tissue permeability predominant in repeated oral route application. Spiny and tiny...

Download PDF file
  • EP ID EP594445
  • DOI 10.26717/BJSTR.2019.13.002410
  • Views 187
  • Downloads 0

How To Cite

Hilda Martínez-Coria, Héctor E López-Valdés (2019). The Connection Between Alzheimer’s Disease and Prion Diseases: A Mini-Review. Biomedical Journal of Scientific & Technical Research (BJSTR), 13(3), 10020-10021. https://europub.co.uk./articles/-A-594445